Floatz logo

Edoxaban

Coronary Artery Atherosclerosis

Asan Medical CenterSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Coronary Artery Atherosclerosis cohort.

Asset / SponsorPhaseRating
ISOSORBIDE DINITRATE
Ukrainian Medical Stomatological Academy
Phase 4BB
Rosuvastatin
Ukrainian Medical Stomatological Academy
Phase 4BB
Bisoprolol Fumarate
Ukrainian Medical Stomatological Academy
Phase 4BB
Acetylsalicylic Acid
Ukrainian Medical Stomatological Academy
Phase 4BB
Pioglitazone
Ukrainian Medical Stomatological Academy
Phase 4BB
Ezetimibe
Samsung Medical Center
Phase 4BB
RAMIPRIL
Ukrainian Medical Stomatological Academy
Phase 4BB
Rimonabant
Sanofi
Phase 3CC

Same molecule, other indications

Edoxaban is also rated in:

atrial fibrillationDormant
A
Indicative ·
83 / 100
View asset →
intracerebral hemorrhageDormant
BBB
Indicative ·
78 / 100
View asset →
EmbolismDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →